<DOC>
	<DOC>NCT01090401</DOC>
	<brief_summary>The objective of this study is to prove the safety and efficacy of the Linox smart S DX ICD lead.</brief_summary>
	<brief_title>Linox Smart S DX PME/Master Study</brief_title>
	<detailed_description />
	<criteria>Patients with standard ICD indication Be available for followup visits on a regular basis at an approved investigational center Patients with standard ICD contraindication Patients with permanent atrial fibrillation Have a life expectancy of less than six months Are expecting to receive cardiac surgery within 6 months after enrollment Age &lt; 18 years Not enrolled in another cardiac clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>